Amino Acid and Peptide-Based Antiviral Agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Virology

Background:

• Many clinically used antiviral agents are derived from amino acids, peptides, or peptidomimetics.
• Drugs like HIV and Hepatitis C Virus (HCV) protease inhibitors have significantly reduced mortality from AIDS and viral hepatitis.
• There is a continuous demand for novel antiviral therapies and improved drug development.

Purpose of the Study:

• To review antiviral agents incorporating amino acids, encompassing both proteinogenic and non-proteinogenic types.
• To emphasize the synthetic challenges associated with creating enantiomerically pure non-proteinogenic amino acid components for these agents.

Main Methods:

• Literature review of antiviral agents based on amino acid structures.
• Focus on synthetic strategies for non-proteinogenic amino acid derivatives.

Main Results:

• Identified numerous antiviral agents utilizing amino acid scaffolds.
• Highlighted the importance of amino acids as versatile building blocks in drug design.
• Discussed synthetic methodologies for obtaining chiral non-proteinogenic amino acids.

Conclusions:

• Amino acid-based compounds represent a vital class of antiviral drugs.
• The synthesis of specific non-proteinogenic amino acid precursors remains a critical area for development.
• Further research into amino acid-based antivirals holds promise for combating viral diseases.